Since 1969
One of the most globally recognised Australian brands, dominating the market with comprehensive multivitamins and targeted wellness blends.
Educational guide · 13 min read
Coenzyme Q10 is the body's primary mitochondrial antioxidant — required for ATP production in every cell. Most people under 50 make enough. After 50, statin users, and people on heart medications may need to supplement. This guide covers what CoQ10 does, the ubiquinone vs ubiquinol controversy, and the dose-by-indication table.
Last updated: August 23, 2026 · Sources: NIH ODS CoQ10, Mortensen 2014, Witte 2015, Langsjoen 2008
Coenzyme Q10 (CoQ10) is a fat-soluble quinone found in every cell of the body, with the highest concentrations in heart, liver, kidney, and pancreas. The body synthesizes CoQ10 from the same pathway that produces cholesterol (the mevalonate pathway). Total body CoQ10 is about 0.5-1.5 grams, with about 95% in the reduced form (ubiquinol) and 5% in the oxidized form (ubiquinone).
CoQ10 is essential because it shuttles electrons in the mitochondrial electron transport chain. Without it, the cell cannot produce ATP efficiently. It also functions as a fat-soluble antioxidant, protecting cell membranes from lipid peroxidation. Unlike most supplements, CoQ10 has measurable clinical outcomes — the Q-SYMBIO trial (Mortensen 2014) showed a 43% reduction in all-cause mortality in chronic heart failure patients taking 300 mg/day CoQ10.
The bottom line: endogenous CoQ10 production peaks around age 20-25 and declines steadily afterward. By age 65, cardiac CoQ10 levels are about 50% of young adult levels. Statin medications deplete CoQ10 by 25-50% via the mevalonate pathway. The three populations most likely to benefit from supplementation: adults over 50, statin users, and people with cardiovascular conditions.
CoQ10 has two main biological roles:
The two forms differ only in oxidation state — but that small chemistry difference translates to large bioavailability difference in adults over 50.
The oxidized form. Most clinical trials (including Q-SYMBIO) used ubiquinone. The body must convert ubiquinone to ubiquinol before use. Healthy adults under 50 convert efficiently. Cheaper per mg — typically 2-3x cheaper than ubiquinol.
Best for: adults <50, cardiovascular support, anyone on a budget, when 200-300 mg/day is achievable.
The active, reduced form. Per Witte 2015, ubiquinol is 2-3x more bioavailable than ubiquinone in adults over 50. Conversion efficiency declines with age (per the same study). More expensive per mg. More prone to oxidation on shelf — check expiry dates.
Best for: adults >50, anyone with documented deficiency, anyone who took ubiquinone without benefit, mitochondrial conditions.
The conversion question: A healthy 30-year-old taking 100 mg ubiquinone will absorb roughly the same as 100 mg ubiquinol (efficient conversion). A healthy 60-year-old taking 100 mg ubiquinol will absorb roughly 2-3x more than 100 mg ubiquinone (impaired conversion). This is why ubiquinol is the form most cardiologists recommend for patients over 50, while ubiquinone is fine for younger adults.
The mevalonate pathway produces both cholesterol AND CoQ10. Statins (atorvastatin, rosuvastatin, simvastatin, pravastatin) inhibit HMG-CoA reductase, blocking the pathway. This lowers cholesterol — but also lowers endogenous CoQ10 by 25-50% per Langsjoen 2008.
The statin + CoQ10 depletion is the primary mechanism behind statin-induced muscle pain (myalgia), which affects 5-10% of statin users. The standard of care per the Mayo Clinic and Cleveland Clinic is to co-supplement with 100-200 mg CoQ10 daily when prescribing a statin.
Clinical evidence: Langsjoen 2008 followed 50 statin patients with statin-induced myalgia. After CoQ10 supplementation (100-300 mg/day), 84% of patients reported improvement in muscle symptoms within 30 days. Discontinuation of CoQ10 led to recurrence in most cases. The mechanism is mitochondrial — depleted CoQ10 impairs ATP production in muscle cells.
There is no RDA for CoQ10 — the body synthesizes it. Therapeutic doses vary widely by indication. The doses below are evidence-based from the cited RCTs.
| Indication | Dose (mg/day) | Form |
|---|---|---|
| Statin users (deficiency correction) | 100-200 | Ubiquinone or ubiquinol |
| Heart failure (chronic, severe) | 300 | Ubiquinone (per Mortensen 2014) |
| Cardiovascular support (general) | 100-200 | Either form |
| Fertility (male sperm quality) | 200-400 | Ubiquinol preferred |
| Migraine prevention | 300 | Ubiquinone (per PMID 26877823) |
| Healthy adults <50 (optional) | 50-100 | Ubiquinone (cheapest) |
Take with a fat-containing meal — CoQ10 is fat-soluble and absorption is 2-3x higher with food. Best pairing: avocado, olive oil, nuts, or a meal containing 10+ g of fat.
Per the Q-SYMBIO trial (Mortensen 2014, 420 patients, 2-year follow-up), 300 mg/day CoQ10 reduced all-cause mortality by 43%, cardiovascular mortality by 43%, and hospital stays by 43%. The most clinically significant supplement trial in cardiology.
Take with cardiologist supervision. Pair with conventional heart failure therapy.
100-200 mg/day CoQ10 ubiquinol. Langsjoen 2008: 84% of statin patients with myalgia improved within 30 days of supplementation. The mechanism is mitochondrial CoQ10 restoration.
Best taken with the statin dose. Don't stop the statin without cardiologist approval.
200-400 mg/day ubiquinol. Safarinejad 2009 + 2012: significant improvement in sperm count, motility, and morphology in subfertile men after 26 weeks. Pregnancy rates also improved.
Pair with selenium (100-200 mcg) and zinc (25-30 mg) for additive benefit.
300 mg/day CoQ10. Shoji 2016 RCT: 600 migraine patients, 50% reduction in attack frequency per month (47.6% vs 14.4% placebo). Comparable to propranolol with better tolerability.
Takes 4-12 weeks to see benefit. Pair with magnesium (400-600 mg/day) and riboflavin (400 mg/day) for additive benefit.
Endogenous CoQ10 production declines ~50% by age 65. Supplementation at 100-200 mg/day may support cardiac, cognitive, and energy levels in adults over 50. Per Hernández-Ojeda 2012, ubiquinol was associated with improved mood and energy in middle-aged adults.
Ubiquinol preferred over age 50 due to conversion efficiency.
100-200 mg/day CoQ10. Rosenfeldt 2007 meta-analysis: 11-17 mmHg reduction in systolic BP, 8-10 mmHg reduction in diastolic. Comparable to first-line antihypertensives for mild hypertension.
Monitor BP if already on antihypertensives — additive effect.
Yes — per the Mayo Clinic and Cleveland Clinic standard of care, statin users should co-supplement with 100-200 mg CoQ10 daily. Statins deplete endogenous CoQ10 by 25-50%, contributing to muscle pain and fatigue. Take with the statin dose, ideally with a fat-containing meal.
For adults over 50, yes — per Witte 2015, ubiquinol is 2-3x more bioavailable, so the cost per absorbed mg is similar. For adults under 50, the conversion is efficient enough that ubiquinone is fine. The cutoff is roughly age 50.
Carefully — CoQ10 has a vitamin-K-like structure and may reduce INR. Per the Mayo Clinic, warfarin patients should NOT start CoQ10 without close monitoring. If adding CoQ10, check INR within 1 week and adjust warfarin dose as needed. Work with your prescriber.
Morning with a fat-containing meal is best. CoQ10 is energizing (it supports ATP production) and can interfere with sleep if taken late in the day. The best pairing is breakfast with avocado, eggs, nuts, or olive oil.
CoQ10 is generally recognized as safe but pregnancy data is limited. Pregnant women with mitochondrial disease or pre-eclampsia risk have been supplemented in clinical trials with no adverse effects, but routine supplementation is not established. Talk to your OB-GYN before starting.
For static deficiency correction (statin users, fatigue): 4-8 weeks. For cardiovascular outcomes (heart failure, BP): 4-12 months. For fertility: 3-6 months — sperm production cycle is 74 days. Patience is required — CoQ10 is not a stimulant.
These 10 brands are featured on every vitfacts.com comparison page. We track them for ingredient transparency, third-party testing, and Thailand availability.
Since 1969
One of the most globally recognised Australian brands, dominating the market with comprehensive multivitamins and targeted wellness blends.
Since 1932
A heritage naturopathic brand spanning over 90 years, known for rigorous ingredient sourcing and massive pharmacy presence throughout the Asia-Pacific region.
Since 1993
A premium, practitioner-only brand (owned by Blackmores) offering highly concentrated, clinical-strength formulas that are frequently recommended by healthcare professionals.
Since 1986
A high-quality pharmacy brand heavily focused on evidence-based ingredients, widely known for its "Inner Health" probiotic range and highly absorbable magnesium powders.
Since 1980s
Born in Australia, this brand formulates therapeutic herbal and nutritional supplements with a strict focus on purity, offering many vegan-friendly options.
Since 1970s
One of Australia's longest-running and most accessible vitamin brands, providing a massive, budget-friendly range found in most major supermarkets and pharmacies.
Since 1984
While based in the US, Thorne is heavily imported and highly sought after by functional medicine practitioners globally—including in both Australia and Thailand. It is considered a gold standard due to its strict four-round testing protocol and complete absence of unnecessary fillers or binders.
Since 2006
An Australian-made value brand founded in 2006, sold through Chemist Warehouse and major AU pharmacies. Part of the Nature's Care family (est. 1990), offering a wide mass-market supplement range covering fish oil, vitamins C/D, magnesium, probiotics, zinc, iron, ashwagandha, collagen, and CoQ10.
Why these 10? See the VitFacts editorial policy page (forthcoming) for the criteria — minimum 10 years of documented safety record, public certificate-of-analysis policy, and verifiable Thailand distribution.